BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28966063)

  • 1. Adaptive gene profiling of Mycobacterium tuberculosis during sub-lethal kanamycin exposure.
    Habib Z; Xu W; Jamal M; Rehman K; Dai J; Fu ZF; Chen X; Cao G
    Microb Pathog; 2017 Nov; 112():243-253. PubMed ID: 28966063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage-specific Mycobacterium tuberculosis genes: identification by green fluorescent protein and kanamycin resistance selection.
    Srivastava V; Rouanet C; Srivastava R; Ramalingam B; Locht C; Srivastava BS
    Microbiology (Reading); 2007 Mar; 153(Pt 3):659-666. PubMed ID: 17322185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
    Kambli P; Ajbani K; Nikam C; Sadani M; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
    Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis.
    Walter ND; Dolganov GM; Garcia BJ; Worodria W; Andama A; Musisi E; Ayakaka I; Van TT; Voskuil MI; de Jong BC; Davidson RM; Fingerlin TE; Kechris K; Palmer C; Nahid P; Daley CL; Geraci M; Huang L; Cattamanchi A; Strong M; Schoolnik GK; Davis JL
    J Infect Dis; 2015 Sep; 212(6):990-8. PubMed ID: 25762787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
    Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD
    Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of rrs gene mutations in amikacin resistant clinical isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Ahmad K; Ahmad Z; Somayya R; Ali A; Rahat S
    Microb Pathog; 2017 Jul; 108():66-70. PubMed ID: 28479509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3192-7. PubMed ID: 16048924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of genes of Mycobacterium tuberculosis upregulated during residence in lungs of infected mice.
    Srivastava V; Jain A; Srivastava BS; Srivastava R
    Tuberculosis (Edinb); 2008 May; 88(3):171-7. PubMed ID: 18054522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China.
    Du Q; Dai G; Long Q; Yu X; Dong L; Huang H; Xie J
    Diagn Microbiol Infect Dis; 2013 Oct; 77(2):138-42. PubMed ID: 23948547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.
    Engström A; Perskvist N; Werngren J; Hoffner SE; Juréen P
    J Antimicrob Chemother; 2011 Jun; 66(6):1247-54. PubMed ID: 21427106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis.
    Alangaden GJ; Kreiswirth BN; Aouad A; Khetarpal M; Igno FR; Moghazeh SL; Manavathu EK; Lerner SA
    Antimicrob Agents Chemother; 1998 May; 42(5):1295-7. PubMed ID: 9593173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.
    Said HM; Kock MM; Ismail NA; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):104-9. PubMed ID: 22236854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular characterization of drug-resistant and extensive-drug resistant isolates of Mycobacterium tuberculosis in Shenzhen of China].
    Gui J; Wang F; Luo DQ; Wang HF; Peng Y; Zhang L
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):276-9. PubMed ID: 20646459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.
    Igarashi Y; Chikamatsu K; Aono A; Yi L; Yamada H; Takaki A; Mitarai S
    Diagn Microbiol Infect Dis; 2017 Dec; 89(4):276-281. PubMed ID: 28974394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Mutation in the 16S rRNA Decoding Region Attenuates the Virulence of Mycobacterium tuberculosis.
    Watanabe S; Matsumura K; Iwai H; Funatogawa K; Haishima Y; Fukui C; Okumura K; Kato-Miyazawa M; Hashimoto M; Teramoto K; Kirikae F; Miyoshi-Akiyama T; Kirikae T
    Infect Immun; 2016 Aug; 84(8):2264-2273. PubMed ID: 27245411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.
    Kurabachew M; Lu SH; Krastel P; Schmitt EK; Suresh BL; Goh A; Knox JE; Ma NL; Jiricek J; Beer D; Cynamon M; Petersen F; Dartois V; Keller T; Dick T; Sambandamurthy VK
    J Antimicrob Chemother; 2008 Oct; 62(4):713-9. PubMed ID: 18587134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis.
    Krüüner A; Jureen P; Levina K; Ghebremichael S; Hoffner S
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2971-3. PubMed ID: 12937004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression analysis of efflux pump genes among drug-susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates and reference strains.
    Calgin MK; Sahin F; Turegun B; Gerceker D; Atasever M; Koksal D; Karasartova D; Kiyan M
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):291-7. PubMed ID: 23561272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing isogenic strains of Beijing genotype Mycobacterium tuberculosis after acquisition of Isoniazid resistance: A proteomics approach.
    Nieto R LM; Mehaffy C; Dobos KM
    Proteomics; 2016 May; 16(9):1376-80. PubMed ID: 26929115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.